# Investigation of Port Catheter-Associated Infections in Childhood Acute Leukemia Patients

## Authors

- Savas Mert Darakci ([ORCID](https://orcid.org/0000-0002-7218-2996)) — Pediatrics and Child Health, Diyarbakır Egil County State Hospital
- Kamil Yilmaz ([ORCID](https://orcid.org/0000-0001-5137-0501)) — Dicle University School of Medicine, Department of Pediatric Infectious Diseases
- Veysiye Hulya Uzel ([ORCID](https://orcid.org/0000-0002-3037-2353)) — Dicle University School of Medicine, Department of Pediatric Hematology and Oncology
- Murat Soker ([ORCID](https://orcid.org/0000-0001-8463-2723)) — Dicle University School of Medicine, Department of Pediatric Hematology and Oncology

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 7, Issue 3 (2021), pages 149–156
- **Article type:** Original Article
- **Published online:** 2021-09-26
- **DOI:** [10.5455/umj.20210526071647](https://doi.org/10.5455/umj.20210526071647)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=83896
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/83896.pdf

## Abstract

Introduction: Port catheters are essential for optimal and comfortable treatment of hematological malignancy. Materials and Methods: Two hundred and ninety-five patients with acute leukemia were analyzed retrospectively. Eighty-five patients with a port catheter (Group-1) who suffered a total of 151 infection attacks and 80 patients without a port catheter (Group-2) who suffered a total of 107 infection attacks were included in the study. Results: The mean age of the patients was 54.80±33.51 months in Group-1 (n:85) and 80.61±45.42 months in Group-2 (n:80) (p

## Keywords

Acute leukemia; port catheter; neutrophil-lymphocyte ratio; platelet lymphocyte ratio

## How to cite

Darakci SM, Yilmaz K, Uzel VH, Soker M. Investigation of Port Catheter-Associated Infections in Childhood Acute Leukemia Patients. Ulutas Med J. 2021;7(3):149-156. doi:10.5455/umj.20210526071647

## References

1. Spector L, Ross J. Epidemiology and etiology: in Pui CH ed. Childhood Leukemias 2nd ed. Cambridge. Cambridge University Press. 2006;48-66 https://doi.org/10.1017/cbo9780511471001.004
2. Seiter K. Acute Lymphoblastic Leukemia [İnternet]. 2019 [a.yer 20 Haziran 2019]. Erişim adresi: https://emedicine.medscape. com/article/207631 156 77 Port Catheter Associated Infections Darakci et al.
3. Pektaş A, Kara A. Cohort Study: Central Venous Catheter-Related Complications in Children with Hematologic Diseases at a Single Center. Tjh. 05 Haziran 2015;32(2):144-51 https://doi.org/10.4274/tjh.2013.0403
4. Coco I, Casale F, Indolfi P. Infections from CVC in the pediatric neoplastic patient. Single institution experience. Minerva Pediatr. Ağustos 2012;64(4):385-94
5. Cecinati V, Brescia L, Tagliaferri L, Giordano P, Esposito S. Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol Infect Dis. Kasım 2012;31(11):2869-77 https://doi.org/10.1007/s10096-012-1652-4
6. Ares G, Hunter CJ. Central venous access in children: indications, devices, and risks. Current Opinion in Pediatrics. Haziran 2017;29(3):340-6 https://doi.org/10.1097/mop.0000000000000485
7. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis. 15 Mayıs 2002;34(10):1362-8 https://doi.org/10.1086/340105
8. Henderson D. Infections due to percutaneous intravascular devices. İçinde: Mandell G, Bennet J, Dolin R, editörler. Principles and Practice of Infectious Diseases,. 5. bs Philadelphia; 2000
9. Sarper N, Zengin E, Çorapçioglu F, Tugay M. Totally implantable central venous access devices in children with hemato-oncologic malignancies: Evaluation of Complications and Comparison of Incidence of Febrile Episodes with Similar Patients Without Central Venous Access Devices. Pediatric Hematology and Oncology. Ocak 2006;23(6):459-70 https://doi.org/10.1080/08880010600712514
10. Miliaraki M, Katzilakis N, Chranioti I, Stratigaki M, Koutsaki M, Psarrou M, vd. Central line-associated bloodstream infection in childhood malignancy: Single-center experience. Pediatrics International. Temmuz 2017;59(7):769-75 https://doi.org/10.1111/ped.13289
11. Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 04 Mart 2011;60(8):243-8 https://doi.org/10.1016/j.annemergmed.2011.07.035
12. Tsai H-C, Huang L-M, Chang L-Y, Lee P-I, Chen J-M, Shao P-L, vd. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy. J Microbiol Immunol Infect. Aralık 2015;48(6):639-46 https://doi.org/10.1016/j.jmii.2014.07.008
13. Adler A, Yaniv I, Solter E, Freud E, Samra Z, Stein J, vd. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol. Ocak 2006;28(1):23-8
14. Walz JM, Memtsoudis SG, Heard SO. Prevention of central venous catheter bloodstream infections. J Intensive Care Med. Haziran 2010;25(3):131-8 https://doi.org/10.3109/9781420075151-76
15. Simon A, Furtwängler R, Graf N, Laws HJ, Voigt S, Piening B, vd. Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on? GMS Hyg Infect Control [İnternet]. 12 Mayıs 2016 [a.yer 20 Aralık 2019];11. Erişim adresi: 10.3205/dgkh000271
16. Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14 https://doi.org/10.1007/bf03656390
17. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 26 Ocak 2012;5:2 https://doi.org/10.1186/1755-7682-5-2
18. Gao Y, Wang W-J, Zhi Q, Shen M, Jiang M, Bian X, vd. Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer. Oncotarget. 27 Eylül 2017;8(51):88835-44 https://doi.org/10.18632/oncotarget.21340
19. Vioral AN, Wentley D. Managing oncology neutropenia and sepsis in the intensive care unit. Crit Care Nurs Q. Haziran 2015;38(2):165-74 https://doi.org/10.1097/cnq.0000000000000058